- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04947891
The Establishment of the Integration of Surgery and Postoperative Intensive Recovery of Patients With CSM
June 27, 2021 updated by: Peking University Third Hospital
The Establishment of the Integration of Posterior Approach Surgical Treatment and Postoperative Intensive Recovery Management of Patients With Degenerative Cervical Spine Myelopathy
This study aims to establish the specialist consensus of the integration of posterior approach surgical treatment and postoperative intensive recovery management for CSM or OPLL patients, and verify its safety, practicability and reliability.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
In order to establish the specialist consensus of the integration of posterior approach surgical treatment and postoperative intensive recovery management, and verify its safety, practicability and reliability, this study enrolled 130 patients with CSM or OPLL undergoing C3-7 open-door laminoplasty.
Patients are divided in two groups randomly.
The study group has 80 patients, treated with postoperative intensive recovery management, and the control group has 50 patients.
The data is collected preoperatively, at 3-month follow-up and 1-year follow-up.
Study Type
Observational
Enrollment (Actual)
130
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100191
- Feifei Zhou
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
17 years to 80 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients with degenerative CSM or OPLL undergoing C3-7 open-door laminoplasty
Description
Inclusion Criteria:
- (1) Age: 18~70 years. (2) Diagnosed as CSM or OPLL. (3) Going to receive C3-C7 open-door laminoplasty. (4) Agree to join this study and sign the informed consent.
Exclusion Criteria:
- (1) Anterior and posterior combined surgery. (2) Posterior laminoplasty combined fusion. (3) Severe osteoporosis. (4) Morbid obesity. (5) patients with mental disorder. (6) patients with previous history of cervical spine surgery. (7) Abnormal laboratory report of liver function, kidney function and hematologic system.(8) Poor compliance. (9) Patients with other surgical contraindications. (10) Patients with intemperance or taking drugs. (11) Patients who joined other study within the last 3 months.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Study group
Patients will be treated with intensive recovery method after surgery.
|
Intensive recovery management includes 3 parts: (1) Preoperative analgesia and airway evaluation.
(2) The protection and reconstruction of the musculo-ligamentous complex during the surgery, the safe intubation, and the local infiltration anesthesia during surgery.
(3) Collar free, multimodal analgesia, airway management, and early recovery after surgery.
|
Control group
Patients will be treated with regular recovery method after surgery.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cervical spine mechanical analysis
Time Frame: Preoperation to 1 year after surgery.
|
The ROM and multi-dimensional mechanical analysis of cervical spine before surgery, at 3-month postoperative follow-up and 1-year follow
|
Preoperation to 1 year after surgery.
|
Cervical spine functions
Time Frame: Preoperation to 1 year after surgery.
|
NDI score and JOACMEQ score before surgery, at 3-month postoperative follow-up and 1-year follow
|
Preoperation to 1 year after surgery.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Outcome of quality of life
Time Frame: Preoperation to 1 year after surgery.
|
EQ-5D score before surgery, at 3-month postoperative follow-up and 1-year follow
|
Preoperation to 1 year after surgery.
|
Outcome of pain
Time Frame: Preoperation to 1 year after surgery.
|
VAS score before surgery, at 3-month postoperative follow-up and 1-year follow
|
Preoperation to 1 year after surgery.
|
Neurological outcome
Time Frame: Preoperation to 1 year after surgery.
|
mJOA score before surgery, at 3-month postoperative follow-up and 1-year follow
|
Preoperation to 1 year after surgery.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Feifei Zhou, M.D., Peking University Third Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 6, 2017
Primary Completion (Actual)
June 15, 2020
Study Completion (Actual)
December 20, 2020
Study Registration Dates
First Submitted
June 27, 2021
First Submitted That Met QC Criteria
June 27, 2021
First Posted (Actual)
July 1, 2021
Study Record Updates
Last Update Posted (Actual)
July 1, 2021
Last Update Submitted That Met QC Criteria
June 27, 2021
Last Verified
June 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- M2017310
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cervical Myelopathy
-
Valérie SchuermansRecruitingCervical Disc Disease | Cervical Fusion | Fusion of Spine | Cervical Spondylosis | Cervical Disc Herniation | Myelopathy Cervical | Cervical Disc Degeneration | Radiculopathy, Cervical | Myelopathy, Compressive | Radiculopathy, Cervical Region | Radiculopathy; in Spondylosis | Radiculopathy; in Intervertebral... and other conditionsNetherlands
-
Cambridge University Hospitals NHS Foundation TrustNational Institute for Health Research, United Kingdom; Wolfson Brain Imaging...RecruitingCervical Spondylosis With Myelopathy | Degenerative Cervical MyelopathyUnited Kingdom
-
Peking University Third HospitalCompleted
-
National Taiwan University HospitalCompletedCervical Radiculopathy | Cervical MyelopathyTaiwan
-
Unity Health TorontoUnknownCervical Radiculopathy | Cervical MyelopathyCanada
-
Shanghai Changzheng HospitalRecruitingMyelopathy CervicalChina
-
CHU de ReimsUnknownCervical Radiculopathy | Cervical Myelopathy | Cervical Spinal FusionFrance
-
University of KentuckyRecruiting
-
Imperial College Healthcare NHS TrustNot yet recruitingCervical Myelopathy
-
University of UtahEnrolling by invitationCervical MyelopathyUnited States
Clinical Trials on Intensive recovery management
-
New York State Psychiatric InstituteEmory UniversityCompletedDepressive Disorder | Bipolar Disorder | Mental Disorders, Severe | Schizophrenia and Related Disorders
-
Wake Forest University Health SciencesCompletedHypertension SecondaryUnited States
-
Wake Forest University Health SciencesNot yet recruiting
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, FranceCompletedActive Second StageFrance
-
Yale UniversityNational Institute of Mental Health (NIMH); VA Connecticut Healthcare SystemCompletedSchizophrenia | Bipolar Disorder | Dual DiagnosisUnited States
-
Hospices Civils de LyonInstitut National de la Santé Et de la Recherche Médicale, FranceRecruiting
-
Hospital Clinic of BarcelonaInstitut d'Investigacions Biomèdiques August Pi i Sunyer; Hospital Sant Joan...Completed
-
National Development and Research Institutes, Inc.National Institute on Drug Abuse (NIDA)Completed
-
Assistance Publique - Hôpitaux de ParisCompleted